Thursday, July 06, 2017 4:07:23 PM
1. Filed an answer to the OIP
1A. Hon. SEC Judge said in below issued statement.
https://www.sec.gov/alj/aljorders/2017/ap-4851.pdf
Respondent Digital Brand Media & Marketing Group, Inc., has filed an answer to the OIP, seeking to dismiss the proceeding against it.
1B. DBMM updates below says it.
http://www.dbmmgroup.com/dbmm-shareholders-update/
The Company was required to respond to the suspension through an “Answer” under the Commission’s Rules of Practice by May 31st. DBMM’s Counsel provided the Company’s response on Friday, May 26th.
2. Filed its Pre-Hearing Conference materials in considerable detail
http://www.dbmmgroup.com/dbmm-shareholders-update-back-basics-business-public-company/
DBMM continues the SEC process as stated in Release No. 4851/June 5, 2017. The Company has filed its Pre-Hearing Conference materials in considerable detail. It developed the Company’s earlier “Answer” in support of DBMM’s response as to why, for the first time, its filings were delayed. The document was prepared by DBMM’s SEC Counsel, Marshal Shichtman, Esq, in collaboration with the Company.
Looks like DBMM is following SEC proceedings as per their recent updates. Also, they mentioned below in recent above update.
Filings will support the same trend as you will see once the reports are filed with the SEC via EDGAR.
Audited 10-K and subsequent filings will document exactly what the Company has stated earlier.
So, looks like filings coming. DBMM making ALL EFFORTS to get OTC Current. DBMM, is in the the hottest sector in the hottest industry. Once, OTC Current, I can't wait to see PPS break above .01 and into Multi Penny.
$DBMM
Recent DBMM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 09:32:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 09:31:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 09:15:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM